Rankings
▼
Calendar
DXCM Q1 2025 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena
DXCM
DexCom, Inc.
$27B
Q1 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$1.0B
+12.5% YoY
Gross Profit
$589M
56.9% margin
Operating Income
$134M
12.9% margin
Net Income
$105M
10.2% margin
EPS (Diluted)
$0.27
QoQ Revenue Growth
-7.0%
Cash Flow
Operating Cash Flow
$184M
Free Cash Flow
$97M
Stock-Based Comp.
$34M
Balance Sheet
Total Assets
$6.8B
Total Liabilities
$4.5B
Stockholders' Equity
$2.3B
Cash & Equivalents
$905M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.0B
$921M
+12.5%
Gross Profit
$589M
$562M
+4.8%
Operating Income
$134M
$101M
+32.2%
Net Income
$105M
$146M
-28.0%
Geographic Segments
UNITED STATES
$751M
72%
Non-US
$286M
28%
← FY 2025
All Quarters
Q2 2025 →